Dai Manaka

1.1k total citations
70 papers, 541 citations indexed

About

Dai Manaka is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dai Manaka has authored 70 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 32 papers in Surgery and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dai Manaka's work include Colorectal Cancer Treatments and Studies (34 papers), Gastric Cancer Management and Outcomes (22 papers) and Cancer Treatment and Pharmacology (20 papers). Dai Manaka is often cited by papers focused on Colorectal Cancer Treatments and Studies (34 papers), Gastric Cancer Management and Outcomes (22 papers) and Cancer Treatment and Pharmacology (20 papers). Dai Manaka collaborates with scholars based in Japan and United States. Dai Manaka's co-authors include Yoshio Yamaoka, Kazue Ozawa, Masahito Kotaka, Takayuki Yoshino, Kaoru Kumada, Atsushi Ohtsu, Masanobu WASHIDA, Etsuro Hatano, Junichi Hasegawa and Yoshihiko Maehara and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Dai Manaka

62 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dai Manaka Japan 14 313 238 162 140 54 70 541
Akiyoshi Kanazawa Japan 14 250 0.8× 270 1.1× 172 1.1× 118 0.8× 74 1.4× 67 561
Andreas Karachristos United States 12 255 0.8× 378 1.6× 82 0.5× 203 1.4× 44 0.8× 34 537
Dennis Tønner Nielsen Denmark 11 253 0.8× 198 0.8× 220 1.4× 126 0.9× 40 0.7× 28 536
Andrea Cacciato Insilla Italy 12 152 0.5× 264 1.1× 153 0.9× 87 0.6× 29 0.5× 26 435
Yuki Imaoka Japan 10 167 0.5× 178 0.7× 130 0.8× 103 0.7× 19 0.4× 87 415
L. James Wudel United States 10 165 0.5× 253 1.1× 98 0.6× 217 1.6× 30 0.6× 14 611
Marion Dhooge France 15 208 0.7× 145 0.6× 75 0.5× 138 1.0× 104 1.9× 51 581
Po‐Da Chen Taiwan 12 127 0.4× 330 1.4× 380 2.3× 117 0.8× 35 0.6× 32 590
Tetsuro Tominaga Japan 17 502 1.6× 322 1.4× 54 0.3× 192 1.4× 54 1.0× 114 737
V. Wong United Kingdom 7 211 0.7× 158 0.7× 173 1.1× 65 0.5× 17 0.3× 10 376

Countries citing papers authored by Dai Manaka

Since Specialization
Citations

This map shows the geographic impact of Dai Manaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Manaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Manaka more than expected).

Fields of papers citing papers by Dai Manaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Manaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Manaka. The network helps show where Dai Manaka may publish in the future.

Co-authorship network of co-authors of Dai Manaka

This figure shows the co-authorship network connecting the top 25 collaborators of Dai Manaka. A scholar is included among the top collaborators of Dai Manaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dai Manaka. Dai Manaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasui, Hisateru, Masato Nakamura, Takashi Sagawa, et al.. (2023). Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16. ESMO Open. 8(5). 101636–101636. 2 indexed citations
2.
Hida, Koya, Suguru Hasegawa, Tomohiro Yamaguchi, et al.. (2023). Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer. International Journal of Clinical Oncology. 28(3). 392–399. 1 indexed citations
3.
Manaka, Dai, et al.. (2022). Re-do laparoscopic esophagojejunostomy for anastomotic stenosis after laparoscopic total gastrectomy in gastric cancer. Langenbeck s Archives of Surgery. 407(7). 3133–3139. 2 indexed citations
4.
5.
Nishitai, Ryuta, et al.. (2021). Intrahepatic bile duct rupture associated with IgG4-related sclerosing cholangitis presenting hepatic inflammatory pseudotumor. Clinical Journal of Gastroenterology. 14(5). 1530–1535. 6 indexed citations
6.
Manaka, Dai, R. Kudo, Naoya Sasaki, et al.. (2020). P-125 Radiomic prediction model for pathological responses of neoadjuvant chemotherapy with S-1 plus oxaliplatin (G-SOX) in clinical stage III gastric cancer. Annals of Oncology. 31. S130–S130. 1 indexed citations
7.
Yoshino, Takayuki, Masahito Kotaka, Katsunori Shinozaki, et al.. (2019). JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer. Cancer Chemotherapy and Pharmacology. 84(6). 1269–1277. 18 indexed citations
8.
9.
10.
Hasegawa, Suguru, Saori Goto, Takuya Matsumoto, et al.. (2017). A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer. Annals of Surgical Oncology. 24(12). 3587–3595. 40 indexed citations
11.
Yoshino, Kenji, et al.. (2017). Metastatic colorectal cancer responsive to regorafenib for 2 years: a case report. Journal of Medical Case Reports. 11(1). 227–227. 6 indexed citations
12.
Nishitai, Ryuta, Junichi Shindoh, T. Yamaoka, et al.. (2016). Biliary architecture of livers exhibiting right-sided ligamentum teres: an indication for preoperative cholangiography prior to major hepatectomy. HPB. 18(11). 929–935. 9 indexed citations
13.
14.
Kanai, Masashi, Takahisa Kawaguchi, Masahito Kotaka, et al.. (2016). Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial). Annals of Oncology. 27(6). 1143–1148. 13 indexed citations
15.
Kotaka, Masahito, Takayuki Yoshino, Koji Oba, et al.. (2015). Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial). Cancer Chemotherapy and Pharmacology. 76(1). 75–84. 24 indexed citations
16.
Yoshino, Kenji, et al.. (2013). A Case of Adult Spontaneous Pneumoperitoneum. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 74(8). 2119–2122. 2 indexed citations
17.
Sakamoto, Katsunori, et al.. (2009). A CASE OF PERINEAL HERNIA AFTER A LAPAROSCOPIC ABDOMINOPERINEAL RESECTION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(9). 2898–2901.
18.
Sakamoto, Katsunori, et al.. (2009). Ileum Penetration and Stenosis due to SMV Thrombosis treated by Elected Surgery. The Japanese Journal of Gastroenterological Surgery. 42(10). 1585–1590. 2 indexed citations
19.
Uehara, Masahiro, et al.. (2008). Gastric Wall Metastasis from Esophageal Carcinoma. Report of a Case. The Japanese Journal of Gastroenterological Surgery. 41(1). 41–45. 3 indexed citations
20.
Baba, Shinji, et al.. (2008). A CASE OF GASTROINTESTINAL STROMAL TUMOR OF LIVER METASTASES WITH SECONDARY RESISTANCE OF IMATINIB. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(11). 2952–2955.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akiyoshi Kanazawa Breakdown of academic impact, for papers by Andreas Karachristos Breakdown of academic impact, for papers by Dennis Tønner Nielsen Breakdown of academic impact, for papers by Andrea Cacciato Insilla Breakdown of academic impact, for papers by Yuki Imaoka Breakdown of academic impact, for papers by L. James Wudel Breakdown of academic impact, for papers by Marion Dhooge Breakdown of academic impact, for papers by Po‐Da Chen Breakdown of academic impact, for papers by Tetsuro Tominaga Breakdown of academic impact, for papers by V. Wong
Rankless by CCL
2026